OTCMKTS:ARFXF

ProMIS Neurosciences Short Interest Ratio and Short Volume

$0.15
-0.01 (-3.39 %)
(As of 07/23/2021 03:28 PM ET)
Add
Compare
Today's Range
$0.15
$0.16
50-Day Range
$0.14
$0.22
52-Week Range
$0.05
$0.23
Volume29,367 shs
Average Volume267,274 shs
Market Capitalization$47.09 million
P/E RatioN/A
Dividend YieldN/A
Beta1.04

ProMIS Neurosciences (OTCMKTS:ARFXF) Short Interest Data

Current Short Volume100 shares
Previous Short Volume4,000 shares
Change Vs. Previous Month-97.50%
Dollar Volume Sold Short$16.85
Short Interest Ratio / Days to Cover0.0
Last Record DateJune, 30 2021
Outstanding Shares305,950,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume29,367 shares
Average Trading Volume267,274 shares
Today's Volume Vs. Average-89.01%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ProMIS Neurosciences ?

Sign up to receive the latest short interest report for ProMIS Neurosciences and its competitors with MarketBeat's FREE newsletter.

ProMIS Neurosciences (OTCMKTS:ARFXF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2021100 shares $16.85 -97.5%N/A0 $0.17
6/15/20214,000 shares $702.80 -98.4%N/A0 $0.18
5/28/2021246,100 shares $42,796.79 +40.5%N/A0.8 $0.17
5/14/2021175,200 shares $25,771.92 +2.6%N/A1.1 $0.15
4/30/2021170,800 shares $24,936.80 +25.0%N/A0.7 $0.15
4/15/2021136,600 shares $18,823.48 -76.7%N/A0.2 $0.14
3/31/2021585,200 shares $99,776.60 +1,870.4%N/A0.7 $0.17
3/15/202129,700 shares $3,192.75 +115.2%N/A0.1 $0.11
2/26/202113,800 shares $1,476.60 -84.5%N/A0.1 $0.11
2/12/202188,900 shares $11,557.00 No ChangeN/A0.1 $0.13
1/15/202132,000 shares $2,672.00 +4.9%N/A0.1 $0.08
12/31/2020700 shares $42.00 -97.8%N/A0 $0.06
12/15/202032,000 shares $2,080.00 +4.9%N/A0.1 $0.07
11/30/202030,500 shares $2,208.20 -45.5%N/A0.1 $0.07
11/15/202056,000 shares $4,155.20 +33.3%N/A0.1 $0.07
10/30/202042,000 shares $3,906.00 +14.8%N/A0.3 $0.09
10/15/202036,600 shares $3,568.50 +266.0%N/A0.1 $0.10
9/30/202010,000 shares $1,074.00 -92.7%N/A0 $0.11
9/15/2020137,600 shares $15,824.00 +48.3%N/A0.4 $0.12

ProMIS Neurosciences (OTCMKTS:ARFXF) Short Interest FAQ

speech bubbles
speech bubbles











What is ProMIS Neurosciences' current short interest?

Short interest is the volume of ProMIS Neurosciences shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 100 shares of ARFXF short. Learn More on ProMIS Neurosciences' current short interest.

Is ProMIS Neurosciences' short interest increasing or decreasing?

ProMIS Neurosciences saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 100 shares, a decrease of 97.5% from the previous total of 4,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ProMIS Neurosciences' short interest compare to its competitors?

0.00% of ProMIS Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "commercial physical research" compare to ProMIS Neurosciences: IQVIA Holdings Inc. (1.50%), Exact Sciences Co. (0.00%), Charles River Laboratories International, Inc. (1.52%), Incyte Co. (2.55%), PPD, Inc. (9.65%), Bitcoin Group SE (0.00%), ICON Public Limited (16.69%), Syneos Health, Inc. (3.92%), Medpace Holdings, Inc. (2.06%), and Anavex Life Sciences Corp. (12.53%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Square, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks.

What does it mean to sell short ProMIS Neurosciences stock?

Short selling ARFXF is an investing strategy that aims to generate trading profit from ProMIS Neurosciences as its price is falling. ProMIS Neurosciences' stock is trading down $0.01 today. To short ProMIS Neurosciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that ProMIS Neurosciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ProMIS Neurosciences?

A short squeeze for ProMIS Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARFXF, which in turn drives the price of the stock up even further.

How often is ProMIS Neurosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARFXF, twice per month. The most recent reporting period available is June, 30 2021.



This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.